CareDx Inc
About CareDx Inc
CareDx, Inc. provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally. The company provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression profiling solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. It also offers HeartCare, which provides information about distinct biological processes, such as immune quiescence, active injury, acute cellular rejection, and antibody mediated rejection; HistoMap Kidney, a solution that identifies allograft rejection and type of rejection in kidney transplant biopsy tissue; and AlloHeme, a monitoring test that predicts relapse in patients with acute myeloid leukemia and myelodysplastic syndromes. In addition, the company provides QTYPE that enables precision in human leukocyte antigen (HLA) typing; Olerup SSP, which is used to type HLA alleles based on sequence specific primer technology; and Ottr, a transplant patient management software. Further, it offers AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a solution that monitors the pharmacokinetics of engraftment and persistence of cells for patients who have received allogeneic cell therapy; and XynQAPI, MedActionPlan, CareDx pharmacy, AlloHome, and HLA Data Systems software solutions. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in Brisbane, California.
- Ticker
- CDNA
- Trading on
- NASDAQ
- ISIN
- -
- Industry
- Diagnostics & Research
- Sector
- Healthcare
- CEO
- John Walter Hanna Jr.
- Headquarters
- 8000 Marina Boulevard, Brisbane, CA, United States, 94005
- Employees
- 761
- Website
- https://caredx.com
Metrics
Analyst Insights & forecasts
Based on information from 8 analysts.
Earnings per share (EPS) forecast
| Q4 • 25 | Q1 • 26 | Q2 • 26 | |
|---|---|---|---|
| Actual | $0.12 | $0.34 | $0.37 |
| Expected | -$0.01 | $0.13 | $0.06 |
| Surprise | 1,300.00% | 161.54% | 516.67% |
| Beat | Beat | Current |
Financial Performance
| Q2 • 26 | Q3 • 26 | QoQ growth | |
|---|---|---|---|
| Revenue | $132M | $139M | 5.62% |
| Net income | $111M | $19.3M | -82.56% |
| Profit margin | 83.85% | 13.84% | -83.49% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.
FAQs
01How much is a CareDx Inc share?
CareDx Inc shares are currently traded for undefined per share.
02How many shares does CareDx Inc have?
CareDx Inc currently has 52.5M shares.
03Does CareDx Inc pay dividends?
No, CareDx Inc doesn't pay dividends.
04What is CareDx Inc 52 week high?
CareDx Inc 52 week high is $90.87.
05What is CareDx Inc 52 week low?
CareDx Inc 52 week low is $15.56.
06What is the 200-day moving average of CareDx Inc?
CareDx Inc 200-day moving average is $37.78.
07Who is CareDx Inc CEO?
The CEO of CareDx Inc is John Walter Hanna Jr..
08How many employees CareDx Inc has?
CareDx Inc has 761 employees.
09What is the market cap of CareDx Inc?
The market cap of CareDx Inc is $3.78B.
10What is the P/E of CareDx Inc?
The current P/E of CareDx Inc is 30.35.
11What is the EPS of CareDx Inc?
The EPS of CareDx Inc is $2.37.
12What is the PEG Ratio of CareDx Inc?
The PEG Ratio of CareDx Inc is -0.12.
13What do analysts say about CareDx Inc?
According to the analysts CareDx Inc is considered a buy.


